Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BlackRock Capital Allocation Term Trust stock logo
BCAT
BlackRock Capital Allocation Term Trust
$14.79
-0.2%
$14.97
$12.91
$16.80
$1.59B0.76533,413 shs524,502 shs
Central Securities Co. stock logo
CET
Central Securities
$49.93
-0.1%
$48.39
$40.24
$50.55
$1.44B0.8425,153 shs21,858 shs
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
$13.61
-1.6%
$13.20
$10.55
$15.68
$399.31M0.7594,322 shs71,940 shs
Oxford Lane Capital Corp. stock logo
OXLC
Oxford Lane Capital
$3.63
+1.7%
$3.82
$3.18
$5.49
$1.65B0.766.85 million shs3.83 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BlackRock Capital Allocation Term Trust stock logo
BCAT
BlackRock Capital Allocation Term Trust
-0.09%+0.05%-1.16%+0.01%-9.97%
Central Securities Co. stock logo
CET
Central Securities
-0.06%+0.58%+2.57%+7.24%+12.57%
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
-1.34%-2.96%+1.57%+10.12%-10.79%
Oxford Lane Capital Corp. stock logo
OXLC
Oxford Lane Capital
+1.68%+6.14%+0.28%-17.31%-31.64%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BlackRock Capital Allocation Term Trust stock logo
BCAT
BlackRock Capital Allocation Term Trust
N/AN/AN/AN/AN/AN/AN/AN/A
Central Securities Co. stock logo
CET
Central Securities
N/AN/AN/AN/AN/AN/AN/AN/A
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/AN/AN/AN/AN/AN/AN/AN/A
Oxford Lane Capital Corp. stock logo
OXLC
Oxford Lane Capital
1.9029 of 5 stars
0.04.01.70.03.20.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BlackRock Capital Allocation Term Trust stock logo
BCAT
BlackRock Capital Allocation Term Trust
0.00
N/AN/AN/A
Central Securities Co. stock logo
CET
Central Securities
0.00
N/AN/AN/A
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
0.00
N/AN/AN/A
Oxford Lane Capital Corp. stock logo
OXLC
Oxford Lane Capital
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BlackRock Capital Allocation Term Trust stock logo
BCAT
BlackRock Capital Allocation Term Trust
$197.67M8.04N/AN/AN/A
Central Securities Co. stock logo
CET
Central Securities
$222.17M6.50N/AN/AN/A
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/AN/AN/AN/AN/AN/A
Oxford Lane Capital Corp. stock logo
OXLC
Oxford Lane Capital
$57.31M28.71N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BlackRock Capital Allocation Term Trust stock logo
BCAT
BlackRock Capital Allocation Term Trust
N/AN/A0.00N/AN/AN/AN/AN/A
Central Securities Co. stock logo
CET
Central Securities
N/AN/A0.00N/AN/AN/AN/AN/A
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/AN/A0.00N/AN/AN/AN/AN/A
Oxford Lane Capital Corp. stock logo
OXLC
Oxford Lane Capital
N/A$0.834.37N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BlackRock Capital Allocation Term Trust stock logo
BCAT
BlackRock Capital Allocation Term Trust
$3.4022.99%N/AN/AN/A
Central Securities Co. stock logo
CET
Central Securities
$2.304.61%N/AN/AN/A
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
$1.8913.89%N/AN/AN/A
Oxford Lane Capital Corp. stock logo
OXLC
Oxford Lane Capital
$1.0829.75%N/A130.12%N/A

Latest HQL, BCAT, OXLC, and CET Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/12/2025
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
quarterly$0.4213.6%8/22/20258/22/20259/30/2025
8/5/2025
BlackRock Capital Allocation Term Trust stock logo
BCAT
BlackRock Capital Allocation Term Trust
monthly$0.272422.8%8/15/20258/15/20258/29/2025
7/3/2025
BlackRock Capital Allocation Term Trust stock logo
BCAT
BlackRock Capital Allocation Term Trust
monthly$0.275522.5%7/15/20257/15/20257/31/2025
7/17/2025
Oxford Lane Capital Corp. stock logo
OXLC
Oxford Lane Capital
$0.0926.67%7/17/20257/18/20257/31/2025
6/4/2025
BlackRock Capital Allocation Term Trust stock logo
BCAT
BlackRock Capital Allocation Term Trust
monthly$0.278222.7%6/13/20256/13/20256/30/2025
6/4/2025
Central Securities Co. stock logo
CET
Central Securities
quarterly$0.252.14%6/17/20256/17/20256/27/2025
(Data available from 1/1/2013 forward)
CompanyEmployeesShares OutstandingFree FloatOptionable
BlackRock Capital Allocation Term Trust stock logo
BCAT
BlackRock Capital Allocation Term Trust
147,000107.46 millionN/ANot Optionable
Central Securities Co. stock logo
CET
Central Securities
628.94 million26.19 millionNot Optionable
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/A28.87 million25.97 millionNot Optionable
Oxford Lane Capital Corp. stock logo
OXLC
Oxford Lane Capital
601453.18 millionN/ANot Optionable

Recent News About These Companies

Trading Or Investing In Oxford Lane Capital Corporation
OXLC: Picking Up The Pieces After The CLOpocalypse
OXLC: 4 Distribution Cuts And A Reverse Split
Time For A History Lesson On OXLC's 26% Yield
OXLC: Deeply Misunderstood 26% Yielding Cash Machine

New MarketBeat Followers Over Time

Media Sentiment Over Time

BlackRock Capital Allocation Term Trust stock logo

BlackRock Capital Allocation Term Trust NYSE:BCAT

$14.79 -0.03 (-0.19%)
Closing price 08/25/2025 03:59 PM Eastern
Extended Trading
$14.81 +0.02 (+0.12%)
As of 08/25/2025 06:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

-

Central Securities stock logo

Central Securities NYSE:CET

$49.93 -0.03 (-0.06%)
As of 08/25/2025 03:59 PM Eastern

Central Securities Corp. is a publicly owned investment manager. The firm invests in the public equity markets of the United States. It also invests on bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks and corporations. Central Securities Corp. was founded on October 1, 1929 and is based in New York City.

abrdn Life Sciences Investors stock logo

abrdn Life Sciences Investors NYSE:HQL

$13.60 -0.23 (-1.63%)
Closing price 08/25/2025 03:58 PM Eastern
Extended Trading
$13.65 +0.04 (+0.33%)
As of 08/25/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Oxford Lane Capital stock logo

Oxford Lane Capital NASDAQ:OXLC

$3.63 +0.06 (+1.68%)
Closing price 08/25/2025 04:00 PM Eastern
Extended Trading
$3.64 +0.00 (+0.14%)
As of 08/25/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Oxford Lane Capital Corp. is a close ended fund launched and managed by Oxford Lane Management LLC. It invests in fixed income securities. The fund primarily invests in securitization vehicles which in turn invest in senior secured loans made to companies whose debt is rated below investment grade or is unrated. Oxford Lane Capital Corp was formed on June 9, 2010 and is domiciled in the United States.